$31.38
0.180.58%
Last update: Nov 4, 4:52 PM
Agios Pharmaceuticals Inc
AGIONASDAQ
The average analyst price target for Agios Pharmaceuticals is $46.15, 47.1% above the current price. Of 10 analysts, 7 rate it Buy and 3 Hold. Targets range from $32 to $65. The latest change came on Oct 29, 2026, when HC Wainwright & Co. assumed coverage of Agios Pharmaceuticals with a Buy rating and a $55 price target.
Price Target Range — 13 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
